Florida / New York

Ph: 561.316.3330

A Publication for the Practicing Medical Specialist, Industry Executive & Investor

MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES

The medical device space is growing rapidly as new startups and investments from major players enter the market. Some of the most notable investors in medical devices include venture capital firms such as Kleiner Perkins Caufield & Byers, Sequoia Capital, and Accel Partners, as well as large companies such as Johnson & Johnson and Medtronic.

This influx of investment is driving innovation in the medical device space, with new devices and treatments being developed all the time. This growth is also creating opportunities for entrepreneurs, who can now launch their own medical device startups and access funding from major players.

Sonitor Introduces SonitorBLU™ and SonitorMOBILE™

“Sonitor is excited to invite healthcare providers, technology partners and all HIMSS attendees to our booth where we will be showcasing the SonitorBLU, Sonitor Sense and SonitorMOBILE suite of products,” said Matt Crane, Chief Commercial Officer, North America/CEO, Sonitor Inc. “In addition, we have recently expanded our team of clinical and technology experts to customize Sonitor’s solutions to meet customers’ strategic objectives and budgets.”

Read More »
Glytec
MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES

Glytec Unveils the Next Evolution of GlucoMetricsⓇ, Giving Hospital Leaders New Insights and Analytics to Improve Glycemic Management and Readiness for New CMS Measures

“CMS is making it clear that hypoglycemia related to insulin is largely preventable, and early treatment and optimal management of severe hyperglycemia is a priority. But it’s hard to enact and measure this type of change without access to data, or the expertise to turn that data into actionable insights,” said Jordan Messler, MD, Chief Medical Officer at Glytec.

Read More »

RAIsonance, Inc. Announces BARDA Contract to Continue Development of the AudibleHealth Dx Diagnostic SaMD for COVID-19 and Influenza Through AI-Powered Cough Analysis

The contract consists of just over $749,000 allocated to the continued development of RAIsonance’s AudibleHealth Dx Diagnostic SaMD. The device is designed to analyze a user’s Forced Cough Vocalization (FCV) in the diagnosis of illness, with the current focus on both COVID-19 and Influenza.

Read More »